Characteristics of subjective cognitive decline associated with amyloid positivity.


Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
10 2022
Historique:
revised: 21 07 2021
received: 09 03 2021
accepted: 22 09 2021
pubmed: 9 12 2021
medline: 21 10 2022
entrez: 8 12 2021
Statut: ppublish

Résumé

The evidence for characteristics of persons with subjective cognitive decline (SCD) associated with amyloid positivity is limited. In 1640 persons with SCD from 20 Amyloid Biomarker Study cohort, we investigated the associations of SCD-specific characteristics (informant confirmation, domain-specific complaints, concerns, feelings of worse performance) demographics, setting, apolipoprotein E gene (APOE) ε4 carriership, and neuropsychiatric symptoms with amyloid positivity. Between cohorts, amyloid positivity in 70-year-olds varied from 10% to 76%. Only older age, clinical setting, and APOE ε4 carriership showed univariate associations with increased amyloid positivity. After adjusting for these, lower education was also associated with increased amyloid positivity. Only within a research setting, informant-confirmed complaints, memory complaints, attention/concentration complaints, and no depressive symptoms were associated with increased amyloid positivity. Feelings of worse performance were associated with less amyloid positivity at younger ages and more at older ages. Next to age, setting, and APOE ε4 carriership, SCD-specific characteristics may facilitate the identification of amyloid-positive individuals.

Identifiants

pubmed: 34877782
doi: 10.1002/alz.12512
pmc: PMC9786747
doi:

Substances chimiques

Amyloid 0
Amyloidogenic Proteins 0
Apolipoprotein E4 0
Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1832-1845

Subventions

Organisme : NIA NIH HHS
ID : U01 AG024904
Pays : United States
Organisme : CIHR
Pays : Canada

Informations de copyright

© 2021 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

Références

Psychol Med. 2004 Nov;34(8):1495-506
pubmed: 15724880
Alzheimers Dement. 2017 May;13(5):550-560
pubmed: 27693187
Alzheimers Dement. 2019 Mar;15(3):465-476
pubmed: 30555032
Alzheimers Dement. 2015 Dec;11(12):1417-1429
pubmed: 25960448
Lancet Neurol. 2013 Oct;12(10):957-65
pubmed: 24012374
Epidemiology. 2010 Jul;21(4):467-74
pubmed: 20220526
J Alzheimers Dis. 2015 Sep 24;48 Suppl 1:S63-86
pubmed: 26402085
Alzheimer Dis Assoc Disord. 2006 Jul-Sep;20(3 Suppl 2):S69-74
pubmed: 16917199
J Alzheimers Dis. 2020;75(3):879-890
pubmed: 32333584
Am J Geriatr Psychiatry. 2013 Jul;21(7):685-95
pubmed: 23567400
Alzheimers Res Ther. 2019 Jul 31;11(1):66
pubmed: 31366409
Alzheimers Dement. 2018 Sep;14(9):1193-1203
pubmed: 29803541
Alzheimers Dement. 2014 Nov;10(6):844-52
pubmed: 24798886
Alzheimers Res Ther. 2018 Aug 7;10(1):76
pubmed: 30081935
Arch Neurol. 2012 Feb;69(2):223-9
pubmed: 22332189
Int J Geriatr Psychiatry. 2000 Nov;15(11):983-91
pubmed: 11113976
Arch Neurol. 1997 Nov;54(11):1399-405
pubmed: 9362989
Ann Neurol. 2010 Mar;67(3):317-24
pubmed: 20373343
Lancet Psychiatry. 2020 Feb;7(2):191-207
pubmed: 31732482
JAMA Psychiatry. 2018 Jan 1;75(1):84-95
pubmed: 29188296
Curr Opin Psychiatry. 2012 Nov;25(6):445-50
pubmed: 23037961
Acta Psychiatr Scand. 2014 Dec;130(6):439-51
pubmed: 25219393
Neurology. 2012 Oct 9;79(15):1570-7
pubmed: 22972644
J Alzheimers Dis. 2015 Sep 24;48 Suppl 1:S87-98
pubmed: 26445275
Alzheimer Dis Assoc Disord. 2005 Jul-Sep;19(3):163-5
pubmed: 16118535
Neurology. 2020 Jul 7;95(1):e46-e58
pubmed: 32522798
JAMA. 2015 May 19;313(19):1939-49
pubmed: 25988463
Neurobiol Aging. 2019 Sep;81:22-29
pubmed: 31207466
Alzheimers Dement (Amst). 2019 Sep 25;11:670-678
pubmed: 31673597
Front Aging Neurosci. 2019 Jan 25;11:7
pubmed: 30760996
J Alzheimers Dis. 2016 Oct 4;54(3):1135-1146
pubmed: 27567852
Lancet Neurol. 2020 Mar;19(3):271-278
pubmed: 31958406
Neuropsychologia. 2012 Oct;50(12):2880-2886
pubmed: 22940426
JAMA. 2015 May 19;313(19):1924-38
pubmed: 25988462
Alzheimers Dement. 2022 Oct;18(10):1832-1845
pubmed: 34877782

Auteurs

Olin Janssen (O)

Alzheimer Centre Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.

Willemijn J Jansen (WJ)

Alzheimer Centre Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.

Stephanie J B Vos (SJB)

Alzheimer Centre Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.

Merce Boada (M)

Fundació ACE, Institut Català de Neurociències Aplicades, Facultat de Medicina, Universitat International de Catalunya-Barcelona, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.

Lucilla Parnetti (L)

Section of Neurology, Center for Memory Disturbances - Lab. of Clinical Neurochemistry, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Tomasz Gabryelewicz (T)

Department of Neurodegenerative Disorders, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.

Tormod Fladby (T)

Department of Neurology, Akershus University Hospital, Lorenskog, Norway.

José Luis Molinuevo (JL)

Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.

Sylvia Villeneuve (S)

Centre for Studies on Prevention of Alzheimer's Disease (StOP-AD) Centre, Montreal, Quebec, Canada.

Jakub Hort (J)

Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.

Stéphane Epelbaum (S)

AP-HP, Hôpital de la Pitié Salpêtrière, Institute of Memory and Alzheimer's Disease (IM2A), Centre of excellence of neurodegenerative disease (CoEN), Department of Neurology, Paris, France.
Inserm Sorbonne Université, Inria, Aramis project-team, Paris Brain Institute - Institut du Cerveau (ICM), Paris, France.

Alberto Lleó (A)

Neurology Department, Hospital de Sant Pau, Barcelona, Spain.

Sebastiaan Engelborghs (S)

Vrije Universiteit Brussel, (VUB) Brussels, and University of Antwerp, Antwerp, Belgium.

Wiesje M van der Flier (WM)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Susan Landau (S)

Helen Wills Neuroscience Institute, University of California, Berkeley, California, USA.

Julius Popp (J)

Department of Geriatric Psychiatry, Psychiatric University Hospital, Zürich, Switzerland.
Old Age Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland.

Anders Wallin (A)

CSIRO Health & Biosecurity, Parkville, Victoria, Australia.
Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.

Philip Scheltens (P)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Marcel Olde Rikkert (MO)

Department of Geriatric Medicine, Radboud Alzheimer Center, Radboud University Medical Center, Nijmegen, The Netherlands.

Peter J Snyder (PJ)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Kingston, The University of Rhode Island, Rhode Island, USA.

Chris Rowe (C)

Department of Molecular Imaging & Therapy, Austin Health, Melbourne, Australia.

Gaël Chételat (G)

Institut National de la Sant. et de la Recherche M.dicale (Inserm), Caen, France.

Agustin Ruíz (A)

Fundació ACE, Institut Català de Neurociències Aplicades, Facultat de Medicina, Universitat International de Catalunya-Barcelona, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.

Marta Marquié (M)

Fundació ACE, Institut Català de Neurociències Aplicades, Facultat de Medicina, Universitat International de Catalunya-Barcelona, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.

Elena Chipi (E)

Section of Neurology, Center for Memory Disturbances - Lab. of Clinical Neurochemistry, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Steffen Wolfsgruber (S)

German Center For Neurodegenerative Diseases/Clinical Research, Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE), Zentrum für klinische Forschung/AG, Cologne, Germany.
Department of Neurodegenerative Diseases and Psychiatry, University Hospital Bonn, Bonn, Germany.

Michael Heneka (M)

Department of Neurodegenerative Diseases and Psychiatry, University Hospital Bonn, Bonn, Germany.

Henning Boecker (H)

Functional Neuroimaging Group, Department of Radiology, University Hospital Bonn, Bonn, Germany.

Oliver Peters (O)

Klinik für Psychiatrie und Psychotherapie, Charité Universitätsmedizin Berlin - CBF, Berlin, Deutschland.

Jonas Jarholm (J)

Department of Neurology, Akershus University Hospital, Lorenskog, Norway.

Lorena Rami (L)

Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.

Adrià Tort-Merino (A)

Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.

Alexa Pichet Binette (AP)

Centre for Studies on Prevention of Alzheimer's Disease (StOP-AD) Centre, Montreal, Quebec, Canada.

Judes Poirier (J)

Centre for Studies on Prevention of Alzheimer's Disease (StOP-AD) Centre, Montreal, Quebec, Canada.

Pedro Rosa-Neto (P)

Centre for Studies on Prevention of Alzheimer's Disease (StOP-AD) Centre, Montreal, Quebec, Canada.

Jiri Cerman (J)

Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.

Bruno Dubois (B)

AP-HP, Hôpital de la Pitié Salpêtrière, Institute of Memory and Alzheimer's Disease (IM2A), Centre of excellence of neurodegenerative disease (CoEN), Department of Neurology, Paris, France.

Marc Teichmann (M)

AP-HP, Hôpital de la Pitié Salpêtrière, Institute of Memory and Alzheimer's Disease (IM2A), Centre of excellence of neurodegenerative disease (CoEN), Department of Neurology, Paris, France.

Daniel Alcolea (D)

Neurology Department, Hospital de Sant Pau, Barcelona, Spain.

Juan Fortea (J)

Neurology Department, Hospital de Sant Pau, Barcelona, Spain.

M Belén Sánchez-Saudinós (MB)

Neurology Department, Hospital de Sant Pau, Barcelona, Spain.

Jarith Ebenau (J)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Cornelia Pocnet (C)

Old Age Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland.

Marie Eckerström (M)

Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.

Louisa Thompson (L)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Kingston, The University of Rhode Island, Rhode Island, USA.

Victor Villemagne (V)

Department of Molecular Imaging & Therapy, Austin Health, Melbourne, Australia.
Department of Psychiatry, University of Pittsburgh, Pittsburgh, USA.

Rachel Buckley (R)

Brigham and Women's Hospital and Department of Neurology Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Samantha Burnham (S)

Section of Neurology, Center for Memory Disturbances - Lab. of Clinical Neurochemistry, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Marion Delarue (M)

Institut National de la Sant. et de la Recherche M.dicale (Inserm), Caen, France.

Yvonne Freund-Levi (Y)

Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

Åsa K Wallin (ÅK)

Department of Clinical Sciences Malmö, Clinical Memory Research Unit, Lund University, Lund, Sweden.

Inez Ramakers (I)

Alzheimer Centre Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.

Magda Tsolaki (M)

Memory and Dementia Center, 3rd Department of Neurology, "G Papanicolau, " General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Hilkka Soininen (H)

Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland.

Harald Hampel (H)

GRC no 21, Alzheimer Precision Medicine (AMP), AP-HP, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.

Luiza Spiru (L)

Carol DAVILA University of Medicine and Pharmacy, Bucharest, Romania.
Geriatrics- Gerontology and Old Age Psychiatry, Alzheimer Unit, Ana Aslan International Foundation - Memory Center and Longevity Medicine, Bucharest, Romania.

Betty Tijms (B)

Alzheimer Centre Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.

Rik Ossenkoppele (R)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.

Frans R J Verhey (FRJ)

Alzheimer Centre Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.

Frank Jessen (F)

Department of Psychiatry, University of Cologne, Cologne, Germany.
German Center For Neurodegenerative Diseases/Clinical Research, Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE), Zentrum für klinische Forschung/AG, Cologne, Germany.

Pieter Jelle Visser (PJ)

Alzheimer Centre Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH